HALOZYME

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Feb 2025 filing date already counts against anyone who files later.

Record

Serial number

99051997

Mark type

Stylized text

Filed

21 Feb 2025

Published for opposition

18 Nov 2025

Attorney of record

Gene K. Park

Goods and services

• Class 005 — Pharmaceuticals: Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; enzymes for medical purposes, namely, for facilitating delivery of fluids or pharmaceuticals; drug delivery agents consisting of pharmaceuticals containing enzymes that facilitate delivery of fluids and a wide range of pharmaceuticals; pharmaceutical preparations for use in the treatment and prevention of metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, dermatological conditions and disorders, and for the treatment of cancer and in hydration; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in aesthetic skin treatments; Hyaluronic acid for pharmaceutical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures; enzymes for medical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures
• Class 035 — Advertising and business services: Administration of a discount program enabling patients to obtain discounts on prescription drugs through use of a discount card provided by a copay discount program; business administration of a program enabling patients to obtain discounts on prescription drugs through a cash-pay program for uninsured and underinsured patients
• Class 036 — Insurance and financial services: Insurance benefits verification and prior authorization assistance in the health industry; copay assistance programs, namely, providing financial assistance to uninsured and underinsured patients for prescription medications
• Class 042 — Scientific and technological services: Scientific research and development services for the integration of technologies, therapies, and other systems for pharmaceuticals and drug delivery systems
• Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of subcutaneous fluid administration; providing medical information in the field of subcutaneous delivery of a wide range of pharmaceuticals

Owner

• Halozyme, Inc., San Diego, CA, US
• Halozyme, Inc., San Diego, CA, US

Prosecution history

• 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 18 Nov 2025 — PUBLISHED FOR OPPOSITION
• 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 21 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 21 Oct 2025 — EXAMINER'S AMENDMENT ENTERED
• 21 Oct 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 21 Oct 2025 — EXAMINERS AMENDMENT E-MAILED
• 21 Oct 2025 — EXAMINERS AMENDMENT -WRITTEN
• 07 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 07 Aug 2025 — NON-FINAL ACTION E-MAILED
• 07 Aug 2025 — NON-FINAL ACTION WRITTEN
• 30 Jul 2025 — ASSIGNED TO EXAMINER
• 30 Jul 2025 — ASSIGNED TO EXAMINER
• 29 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED